PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY

This adverse event was reported 77 times

These drugs are most commonly taken by patients reporting PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY:

# Drug Count
0 PACLITAXEL 14
1 PACLITAXEL (AIBUMIN-BOUND) 14
2 BEVACIZUMAB 10
3 DENOSUMAB 8
4 EVEROLIMUS 8
5 FULVESTRANT 8
6 CAPECITABINE 7
7 CARBOPLATIN 7
8 EXEMESTANE 7
9 MACITENTAN 7
See all common drugs associated with PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY

PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TALETRECTINIB 1 0.0092
1 TISLELIZUMAB-JSGR 1 0.0045
2 MIGLITOL 3 0.0031
3 DOBUTAMINE 5 0.0013
4 NITRIC OXIDE 6 0.0013
5 ENTRECTINIB 2 0.0012
6 ILOPROST 1 0.0011
7 AVELUMAB 2 0.0005
8 NERATINIB 1 0.0004
9 SITAGLIPTIN PHOSPHATE 1 0.0004
See all drugs enriched for association with PULMONARY TUMOUR THROMBOTIC MICROANGIOPATHY